The amount patients pay out-of-pocket for Mylan’s life-saving EpiPen device increased drastically since 2007, according to a study in JAMA Internal Medicine. For the study, researchers used the Truven ...
Cancer patients who have health plans with high deductibles may approach treatment differently because of high out-of-pocket costs, a Dec. 22 Jama Network Open study found. The study of nearly 135,000 ...
Out-of-pocket costs increased by an average of $592.53 per month in the six months after a cancer diagnosis, according to a recent study published in JAMA Network Open. The study analyzed a sample of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results